HAEMONETICS CORP Shares Outstanding

Quick Answer

HAEMONETICS CORP reported Shares Outstanding of 48.22 million shares for fiscal year 2025.

HAEMONETICS CORP Shares Outstanding — Annual History

Fiscal Year Shares Outstanding YoY Change
2025 48.22M -5.1%
2024 50.79M +0.7%
2023 50.45M -1.3%
2022 51.12M +0.5%
2021 50.87M +1.1%
2020 50.32M -1.4%
2019 51.02M -2.5%
2018 52.34M +0.2%
2017 52.26M +2.6%
2016 50.93M -1.4%
2015 51.67M -0.7%
2014 52.04M +2.0%
2013 51.03M +0.8%
2012 50.60M +97.2%
2011 25.66M +0.9%
2010 25.44M

Quarterly Shares Outstanding

Quarter Ending Shares Outstanding YoY QoQ
December 31, 2025 46.83M -6.8% +0.2%
September 30, 2025 46.75M -7.2% -2.9%
June 30, 2025 48.16M -5.9% -0.1%
March 31, 2025 48.22M -5.1% -4.0%
December 31, 2024 50.24M -1.1% -0.3%
September 30, 2024 50.38M -0.7% -1.5%
June 30, 2024 51.15M +0.9% +0.7%
March 31, 2024 50.79M +0.7% +0.0%
  • HAEMONETICS CORP showed a decrease of -5.1% in Shares Outstanding compared to the prior fiscal year.
  • Over the 2010–2025 period, HAEMONETICS CORP’s shares outstanding has grown by 89.5% (from 25.44 million shares to 48.22 million shares).
  • The most recent figure is from HAEMONETICS CORP’s fiscal year 2024 report (Form 10-K), filed with the SEC on May 21, 2025.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment